Literature DB >> 26414802

Experience With the Priority Review Voucher Program for Drug Development.

Aaron S Kesselheim1, Lara R Maggs1, Ameet Sarpatwari1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26414802     DOI: 10.1001/jama.2015.11845

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Association of the Priority Review Voucher With Neglected Tropical Disease Drug and Vaccine Development.

Authors:  Nina Jain; Thomas Hwang; Jessica M Franklin; Aaron S Kesselheim
Journal:  JAMA       Date:  2017-07-25       Impact factor: 56.272

2.  Antileishmanial Activity of Ezetimibe: Inhibition of Sterol Biosynthesis, In Vitro Synergy with Azoles, and Efficacy in Experimental Cutaneous Leishmaniasis.

Authors:  Valter Viana Andrade-Neto; Edézio Ferreira Cunha-Júnior; Marilene Marcuzzo do Canto-Cavalheiro; Geórgia Correa Atella; Talita de Almeida Fernandes; Paulo Roberto Ribeiro Costa; Eduardo Caio Torres-Santos
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

3.  Incentives for Starting Small Companies Focused on Rare and Neglected Diseases.

Authors:  Sean Ekins; Jill Wood
Journal:  Pharm Res       Date:  2015-12-14       Impact factor: 4.200

4.  Access to benznidazole for Chagas disease in the United States-Cautious optimism?

Authors:  Jonathan D Alpern; Rogelio Lopez-Velez; William M Stauffer
Journal:  PLoS Negl Trop Dis       Date:  2017-09-14

5.  Priorities for the Priority Review Voucher.

Authors:  David B Ridley
Journal:  Am J Trop Med Hyg       Date:  2016-08-29       Impact factor: 2.345

6.  Antiparasitic Drugs in the United States-Two Roads to High Prices.

Authors:  Arman A Shahriar; Jonathan D Alpern
Journal:  Front Sociol       Date:  2020-10-22

7.  Imipramine alters the sterol profile in Leishmania amazonensis and increases its sensitivity to miconazole.

Authors:  Valter Viana Andrade-Neto; Thaís Martins Pereira; Marilene do Canto-Cavalheiro; Eduardo Caio Torres-Santos
Journal:  Parasit Vectors       Date:  2016-03-31       Impact factor: 3.876

8.  Open drug discovery for the Zika virus.

Authors:  Sean Ekins; Daniel Mietchen; Megan Coffee; Thomas P Stratton; Joel S Freundlich; Lucio Freitas-Junior; Eugene Muratov; Jair Siqueira-Neto; Antony J Williams; Carolina Andrade
Journal:  F1000Res       Date:  2016-02-09

Review 9.  Research for new drugs for elimination of onchocerciasis in Africa.

Authors:  Annette C Kuesel
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-05-19       Impact factor: 4.077

10.  The Tropical Disease Priority Review Voucher: A Game-Changer for Tropical Disease Products.

Authors:  Jonathan Berman; Tanya Radhakrishna
Journal:  Am J Trop Med Hyg       Date:  2016-08-29       Impact factor: 2.345

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.